Clinical Trials Search Results

A phase III trial in metastatic untreated renal cell cancer.

This precision medicine cancer treatment trial seeks to determine whether treating cancer based on specific genetic changes is effective.

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.